Inventor · disambiguated record
Shanta Bantia
Also filed as: BANTIA SHANTA
21 granted patents·15 pending applications·126 citations·filing 1999–2023
94Inventor score
Files withBIOCRYST PHARM INC24NITOR THERAPEUTICS4BANTIA SHANTA3BABU YARLAGADDA S2BABU YARLAGADDA SUDHAKARA1
Top patents by PatentIndex Score
36 records- 0190US11173159B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2019·Granted Nov 16, 2021·3 cites·20 claims
- 0290US9492452B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2014·Granted Nov 15, 2016·9 cites·30 claims
- 0389US10420769B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2018·Granted Sep 24, 2019·4 cites·20 claims
- 0489US10022375B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2016·Granted Jul 17, 2018·5 cites·32 claims
- 0589US6656915B1Inhibiting T-cell proliferationBIOCRYST PHARM INC·Filed 2000·Granted Dec 2, 2003·47 cites·9 claims
- 0689US6503745B1Cyclopentane and cyclopentene compounds and use for detecting influenza virusBIOCRYST PHARM INC·Filed 1999·Granted Jan 7, 2003·42 cites·39 claims
- 0781US11110092B2Methods of treating hematologic cancersBIOCRYST PHARM INC·Filed 2019·Granted Sep 7, 2021·1 cites·6 claims
- 0881US9770427B2Antiviral treatmentsBIOCRYST PHARM INC·Filed 2014·Granted Sep 26, 2017·3 cites·18 claims
- 0979US2024100055A1Methods of treating hematologic cancersBIOCRYST PHARM INC·Filed 2023·Application pending·0 cites
- 1078US12508266B2Methods and compositions for inhibition of polymeraseISLAND PHARMACEUTICALS LTD·Filed 2021·Granted Dec 30, 2025·0 cites·18 claims
- 1177US12121503B2Antiviral treatmentsBIOCRYST PHARM INC·Filed 2021·Granted Oct 22, 2024·0 cites·13 claims
- 1277US9499554B2Anti-influenza compositions and methodsBIOCRYST PHARM INC·Filed 2014·Granted Nov 22, 2016·1 cites·24 claims
- 1377US6660719B2Inhibiting T-Cell proliferationBIOCRYST PHARM INC·Filed 2001·Granted Dec 9, 2003·7 cites·13 claims
- 1476US11464755B2Antiviral treatmentsBIOCRYST PHARM INC·Filed 2019·Granted Oct 11, 2022·0 cites·23 claims
- 1575US9616129B2Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potencyNITOR THERAPEUTICS·Filed 2014·Granted Apr 11, 2017·1 cites·10 claims
- 1675US8778997B2Antiviral treatmentsBABU YARLAGADDA SUDHAKARA·Filed 2011·Granted Jul 15, 2014·3 cites·8 claims
- 1773US11975003B2Methods and compositions for treatment of Zika virus infectionBIOCRYST PHARM INC·Filed 2021·Granted May 7, 2024·0 cites·9 claims
- 1870US2022040188A1Methods of treating hematologic cancersBIOCRYST PHARM INC·Filed 2021·Application pending·0 cites
- 1968US10933066B2Methods and compositions for treatment of Zika virus infectionBIOCRYST PHARM INC·Filed 2019·Granted Mar 2, 2021·0 cites·12 claims
- 2063US10512649B2Methods and compositions for treatment of zika virus infectionBIOCRYST PHARM INC·Filed 2017·Granted Dec 24, 2019·0 cites·22 claims
- 2162US9452217B2Methods for potentiating immune response for the treatment of infectious diseases and cancerBANTIA SHANTA·Filed 2014·Granted Sep 27, 2016·0 cites·9 claims
- 2261US2011038858A1Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agentsBIOCRYST PHARM INC·Filed 2008·Application pending·0 cites
- 2360US2007203241A1Antiviral treatmentsBABU YARLAGADDA S·Filed 2007·Application pending·0 cites
- 2458US10391075B2Antiviral treatmentsBIOCRYST PHARMACEUTICALS·Filed 2017·Granted Aug 27, 2019·0 cites·21 claims
- 2558US2019224224A1Guanosine as an Immune Potentiator Mediated through Toll ReceptorsNITOR THERAPEUTICS·Filed 2019·Application pending·0 cites
- 2657US10278984B2Guanosine as an immune potentiator mediated through toll receptorsNITOR THERAPEUTICS·Filed 2014·Granted May 7, 2019·0 cites·7 claims
- 2757US2014178372A1Methods of treating hematologic cancersBIOCRYST PHARM INC·Filed 2014·Application pending·0 cites
- 2855US2005187170A1Enhancing the efficiency of RNA polymerase inhibitors by using inosine monophosphate dehydrogenase inhibitorsBIOCRYST PHARM INC·Filed 2004·Application pending·0 cites
- 2953US2017137429A1Anti-influenza compositions and methodsBIOCRYST PHARM INC·Filed 2016·Application pending·0 cites
- 3052US2015291596A1Antiviral azasugar-containing nucleosidesBIOCRYST PHARM INC·Filed 2013·Application pending·0 cites
- 3152US2013331404A1Methods and Compositions for Inhibition of PolymeraseBANTIA SHANTA·Filed 2011·Application pending·0 cites
- 3251US2007244193A1Intramuscular antiviral treatmentsBABU YARLAGADDA S·Filed 2006·Application pending·0 cites
- 3347US2017267681A1Antiviral azasugar-containing nucleosidesBIOCRYST PHARM INC·Filed 2017·Application pending·0 cites
- 3446US2005250728A1Enhancing the efficacy of reverse transcriptase and dna polymerase inhibitors (nucleoside analogs) using pnp inhibitors and/or 2'-deoxyguanosine and/or prodrug thereofBANTIA SHANTA·Filed 2003·Application pending·0 cites
- 3543US2017209447A1Use of PNP Inhibitor to Treat Relapse of Malignancy after Hematopoietic Stem Cell TransplantNITOR THERAPEUTICS·Filed 2014·Application pending·0 cites
- 3641US2011015264A1Intramuscular antiviral treatmentsBIOCRYST PHARM INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shanta Bantia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →